The GMAP Resource Mobilization Strategy estimates the global need for resources at US$26.9 billion for 2012-2015. This estimate includes the cost of providing interventions in countries, financing research and development agenda.
At least US$800 million is needed annually between 2010 and 2015 for global research and development, notably for the development of drugs, vaccines and diagnostics, vector control and analysis of effectiveness and impact – as well as for the research and development components of the Global Plan for Artemisinin Resistance Containment and the Global Plan for Insecticide Resistance Management.
Most of the global funding needs for support to countries are expected to be addressed through existing and forecasted commitments. A major funding challenge remains in Sub-Saharan Africa, where US$3 billion is needed for the period 2014-2016 for commodities and supportive actions (as of April 2014).
Much of the remaining funding gap is to fight resistance to drugs or insecticides. The gap for Asia, the Middle East and Latin America and the Caribbean can largely be met by maintaining current levels of international aid and domestic investments.